Lu Kang Pharmaceutical (600789.SH): Selecisib obtains approval notice for the application for listing of chemical raw materials.

Zhijian Finance and Economics APP News, LUKANG Pharmaceutical (600789.SH) announced that recently, the company received the "Chemical raw materials pharmaceutical market application approval notice" (Notice number: 2025YS00356) issued by the National Medical Products Administration regarding Selaixib. The drug has been approved for market application.